博安生物(06955)股东将股票由中信证券经纪香港转入香港上海汇丰银行 转仓市值8.48亿港元

Group 1 - The core point of the article highlights that on February 2, Boan Biotechnology (06955) transferred shares from CITIC Securities Brokerage Hong Kong to HSBC Hong Kong, with a market value of HKD 848 million, accounting for 16.37% of the total shares [1] - The company announced that its board has been informed by its controlling shareholder, Green Leaf Pharmaceutical Group, regarding a proposed transfer of 11.9866 million H-shares by its wholly-owned subsidiary, Shandong Green Leaf Pharmaceutical Co., Ltd., scheduled for January 27, 2026 [1]